05
Animal feed additive for use as a nutritional supplement for
medical purposes; animal feed supplements; anti-diabetic
pharmaceuticals; anti-diabetic preparations; antidiabetic
preparations; dietary and nutritional supplements; dietary
and nutritional supplements for endurance sports; dietary
and nutritionally fortified food products adapted for
medical use; dietary beverage supplements for human
consumption in liquid and dry mix form for therapeutic
purposes; dietary drink mix for use as a meal replacement
(terms too vague in the opinion of the International Bureau
– Rule 13 (2) (b) of the Regulations); dietary food
supplements; dietary pet supplements in the form of pet
treats; dietary supplement beverage for aiding nerve health;
dietary supplemental drinks; dietary supplemental drinks in
the nature of vitamin and mineral beverages; dietary
supplements; dietary supplements for animals; dietary
supplements for human consumption; dietary supplements for
pets; dietary supplements for pets in the nature of a
powdered drink mix; dietary supplements for aiding nerve
health; feed supplements for pets, livestock; food
supplements; food supplements for aiding nerve health; foods
for individuals with special dietary requirements
necessitated by medical treatments; health food supplements;
homeopathic supplements; liquid nutritional supplement; meal
replacement and dietary supplement drink mixes; medicated
supplements for foodstuffs for animals; natural supplements
for treating depression and anxiety; non-medicated additives
for animal feed for use as nutritional supplements;
nutraceuticals for use as a dietary supplement;
nutraceuticals for use as a dietary supplement for aiding
nerve health; nutritional additives for medical purposes for
use in foods and dietary supplements for human consumption;
nutritional additives for medical purposes used in foods and
dietary supplements for human consumption; nutritional and
dietary supplements formed and packaged as bars; nutritional
supplements; nutritional supplements for aiding nerve
health; nutritional supplements in capsule form for dogs;
nutritional supplements in lotion form sold as a component
of nutritional skin care products; ophthalmic preparations;
ophthalmologic preparations; ophthalmological preparations;
pharmaceutical preparations acting on the central nervous
system; pharmaceutical preparations and substances for the
treatment of damaged skin and tissue; pharmaceutical
preparations and substances for the treatment of infectious
diseases, blood disorders, pain, inflammation, sepsis,
alopecia, obesity and cognitive disorders; pharmaceutical
preparations and substances for the treatment of psychiatric
diseases and disorders; pharmaceutical preparations for the
prevention and treatment of disorders of the nervous system,
the immune system, the cardio-vascular system, the metabolic
system, the respiratory system, the musculo-skeletal system,
the genitourinary system; for the treatment of inflammatory
disorders (terms linguistically incorrect in the opinion of
the International Bureau – Rule 13 (2) (b) of the
Regulations); for use in dermatology, oncology, hematology
and in tissue and organ transplantation, in ophthalmology
and for gastroenterological disorders (terms linguistically
incorrect in the opinion of the International Bureau – Rule
13 (2) (b) of the Regulations); pharmaceutical preparations
for the prevention and treatment of ocular disorders or
diseases, bacteria-based diseases or disorders, autoimmune
diseases or disorders, kidney diseases or disorders, and
diabetes; pharmaceutical preparations for the prevention of
nervous system damage; pharmaceutical preparations for the
treatment and prevention of nervous system damage;
pharmaceutical preparations for the treatment of eye
diseases and conditions; pharmaceutical preparations for the
treatment of kidney diseases; pharmaceutical preparations
for the treatment of nervous system damage; pharmaceutical
preparations for treating diabetes; pharmaceutical
preparations for treating skin disorders; pharmaceutical
preparations for use in chemotherapy; pharmaceutical
preparations for nervous system damage; pharmaceutical
preparations, namely, a topical preparation for the
treatment of ocular disorders prescribed by
ophthalmologists, eye surgeons, and optometrists;
pharmaceutical preparations, namely, antidepressants;
pharmaceutical products for ophthalmological use;
pharmaceutical products for the prevention and treatment of
cancer; powdered nutritional supplement drink mix;
preparation for the relief of pain; therapeutic
pharmaceutical for the treatment of nervous system damage
(terms linguistically incorrect in the opinion of the
International Bureau – Rule 13 (2) (b) of the Regulations);
veterinary preparations for nervous system damage;
veterinary preparations, namely, pain relief medication;
vitamins and dietary food supplements for animals
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen